These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 865536)

  • 21. [Drug metabolism in newborn infant (author's transl)].
    Abucewicz A; Szyszka K
    Przegl Lek; 1973; 30(7):596-9. PubMed ID: 4583911
    [No Abstract]   [Full Text] [Related]  

  • 22. [Changes in drug kinetics in liver diseases and their importance in rational pharmacotherapy].
    Danysz A
    Pol Tyg Lek; 1977 Dec; 32(52):2057-60. PubMed ID: 604977
    [No Abstract]   [Full Text] [Related]  

  • 23. Protein binding and kinetics of drugs in liver diseases.
    Blaschke TF
    Clin Pharmacokinet; 1977; 2(1):32-44. PubMed ID: 322909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impairment of drug elimination in patients with liver disease.
    Narang AP; Datta DV; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):28-32. PubMed ID: 3988389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of drugs in reduced liver function].
    Spigset O
    Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2645-6. PubMed ID: 16215611
    [No Abstract]   [Full Text] [Related]  

  • 26. Liver disease and drug therapy.
    Black M
    Med Clin North Am; 1974 Sep; 58(5):1051-7. PubMed ID: 4608944
    [No Abstract]   [Full Text] [Related]  

  • 27. Clearance by the liver: current concepts in understanding the hepatic disposition of drugs.
    Larrey D; Branch RA
    Semin Liver Dis; 1983 Nov; 3(4):285-97. PubMed ID: 6359424
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug therapy: drug disposition in old age.
    Greenblatt DJ; Sellers EM; Shader RI
    N Engl J Med; 1982 May; 306(18):1081-8. PubMed ID: 7040951
    [No Abstract]   [Full Text] [Related]  

  • 29. Disease as one of many variables affecting drug disposition and response: alterations of drug disposition in liver disease.
    Vesell ES
    Drug Metab Rev; 1978; 8(2):265-91. PubMed ID: 363385
    [No Abstract]   [Full Text] [Related]  

  • 30. [Theophylline pharmacokinetics in patients with liver diseases with reference to estimated hepatic blood flow].
    Nomura F; Ohnishi K; Ohto M; Takeda Y; Rikihisa T; Kanakubo Y
    Rinsho Byori; 1991 Oct; 39(10):1093-7. PubMed ID: 1762184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of liver disease on drug disposition in man.
    Wilkinson GR; Schenker S
    Biochem Pharmacol; 1976 Dec; 25(24):2675-81. PubMed ID: 795432
    [No Abstract]   [Full Text] [Related]  

  • 32. [Drug therapy in liver diseases: problems in intensive care].
    Follath F
    Schweiz Med Wochenschr; 1986 Apr; 116(17):549-52. PubMed ID: 3715434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacokinetics in liver cirrhosis].
    Ackermann E
    Z Gesamte Inn Med; 1977 Jan; 32(1):29-33. PubMed ID: 855389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The significance of age dependent organ changes for therapy].
    Platt D
    Aktuelle Gerontol; 1982 Nov; 12(6):220-2. PubMed ID: 6130716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drug dosing in chronic hepatic disease (author's transl)].
    Gugler R; Eichelbaum M
    Leber Magen Darm; 1981 Apr; 11(2):81-7. PubMed ID: 7015045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug metabolism and liver disease in India.
    Narang AP; Kaur U; Bambery P
    Drug Metab Rev; 1991; 23(1-2):65-81. PubMed ID: 1868778
    [No Abstract]   [Full Text] [Related]  

  • 37. The theophylline disposition after caffeine administration in liver cirrhosis: an index of liver function.
    Hartleb M; Romańczyk T; Becker A; Mańczyk I; Waluga M; Spalińska M; Zieliński M
    Ital J Gastroenterol; 1992; 24(6):332-7. PubMed ID: 1515659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Does the elimination of medication interest the physician?].
    Singlas E
    Sem Hop; 1981 Oct 18-25; 57(39-40):1648-52. PubMed ID: 6119792
    [No Abstract]   [Full Text] [Related]  

  • 39. Terminal half-lives of drugs studied in patients with hepatic diseases.
    Closson RG
    Am J Hosp Pharm; 1977 May; 34(5):520-4. PubMed ID: 326043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of dietary protein on drug clearance.
    Berlinger WG
    Iowa Med; 1986 Feb; 76(2):74, 76, 79. PubMed ID: 3957612
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.